Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Inverness Medical Innovations has closed its previously announced public offering by selling a total of 13.7 million shares at a public offering price of $61.49 per share and raised net proceeds of approximately $806.4 million.
Subscribe to our email newsletter
The total number of shares sold by the company included 1.8 million shares sold to the underwriters upon their exercise of their over-allotment option in full. Certain selling stockholders of the company also sold 165,698 shares of common stock in the offering.
UBS Investment Bank, Jefferies & Company and Merrill Lynch & Co. are acting as joint book-running managers for the offering. Leerink Swann and Stifel, Nicolaus & Company are acting as co-managers for the offering.